N-Acetyl-L-phenylalanine

N-Acetyl-L-phenylalanine (CAS No.: 2018-61-3) is an endogenous acylamino acid derivative generated through the acetylation of L-phenylalanine by acetyl-CoA and is widely recognized as a metabolite arising from both host and gut microbial metabolism. Functionally, it serves as an intermediate and regulatory component in amino acid metabolism and protein acylation processes, reflecting cellular metabolic status and acetylation dynamics in bacterial systems such as Escherichia coli. In biomedical research, N-Acetyl-L-phenylalanine is utilized as a metabolic biomarker for investigating alterations in amino acid turnover, microbial-host interactions, and disease-associated metabolic reprogramming, with reported elevations observed in conditions such as viral infections and neurodegenerative disorders, suggesting its relevance in systemic and central nervous system metabolic profiling. Although no direct molecular targets or canonical signaling pathways have been definitively established, its involvement in metabolic networks linked to phenylalanine catabolism and acylation pathways supports its use in pathway elucidation and metabolic flux analysis. Experimental applications typically include metabolomics studies, kidney function research, and investigations into microbial metabolism or pathogenic intervention strategies, with in vitro studies generally employing concentrations in the micromolar range depending on assay design. Its utility in drug discovery lies primarily in its role as a reference metabolite for biomarker identification and as a tool compound for probing metabolic adaptations in disease models and therapeutic response evaluation.